FDA Inspection
Grifols Therapeutics LLCGrifols Therapeutics LLC – FDA Inspection, May 6, 2022
Record Details
This FDA Inspection record concerns Grifols Therapeutics LLC, with an inspection on May 6, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Grifols Therapeutics LLC
- Inspection Date
- May 6, 2022
- Product Type
- Biologics
View Company Profile
ID · 9cf52920-d34b-4f87-840d-e52213631e5a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1176467
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Grifols Therapeutics LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | Atlanta District Office | Blood and Blood Products |
| September 1, 2023 | Not classified | Atlanta District Office | |
| December 13, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2017 | Not classified | Atlanta District Office | |
| October 21, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Therapeutics LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.